Belfast biotech company Amply raises $1.75m in seed funding to expedite cancer drug discovery, led by Twin Path Ventures.

Belfast-founded biotech company Amply Discovery has raised $1.75 million in seed funding to develop innovative medicines using its AI-driven drug discovery platform. The round was led by Twin Path Ventures, with participation from several investors. The funding will be used to accelerate the development of its discovery programmes through the preclinical stage. Amply is focused on tackling aggressive cancers and drug-resistant infections.